These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23651043)
1. Design and development of (99m)tc-'4+1'-labeled dextran-mannose derivatives as potential radiopharmaceuticals for sentinel lymph node detection. Giglio J; Fernández S; Jentschel C; Pietzsch HJ; Papadopoulos M; Pelecanou M; Pirmettis I; Paolino A; Rey A Cancer Biother Radiopharm; 2013 Sep; 28(7):541-51. PubMed ID: 23651043 [TBL] [Abstract][Full Text] [Related]
2. New (99m)Tc(CO)(3) mannosylated dextran bearing S-derivatized cysteine chelator for sentinel lymph node detection. Pirmettis I; Arano Y; Tsotakos T; Okada K; Yamaguchi A; Uehara T; Morais M; Correia JD; Santos I; Martins M; Pereira S; Triantis C; Kyprianidou P; Pelecanou M; Papadopoulos M Mol Pharm; 2012 Jun; 9(6):1681-92. PubMed ID: 22519912 [TBL] [Abstract][Full Text] [Related]
3. Mannosylated dextran derivatives labeled with fac-[M(CO)₃]+ (M = (99m)Tc, Re) for specific targeting of sentinel lymph node. Morais M; Subramanian S; Pandey U; Samuel G; Venkatesh M; Martins M; Pereira S; Correia JD; Santos I Mol Pharm; 2011 Apr; 8(2):609-20. PubMed ID: 21299250 [TBL] [Abstract][Full Text] [Related]
4. Studies toward the biological efficacy of (99m)Tc-labeled dextran-cysteine-mannose ([(99m)Tc(CO)(3)]DCM20) for sentinel lymph node detection. Subramanian S; Pandey U; Papadopoulos M; Pirmettis I; Venkatesh M; Samuel G Cancer Biother Radiopharm; 2012 Aug; 27(6):365-70. PubMed ID: 22690877 [TBL] [Abstract][Full Text] [Related]
5. Comparative Study of a Series of Papasavva A; Shegani A; Kiritsis C; Roupa I; Ischyropoulou M; Makrypidi K; Pilatis I; Loudos G; Pelecanou M; Papadopoulos M; Pirmettis I Molecules; 2021 Aug; 26(16):. PubMed ID: 34443384 [TBL] [Abstract][Full Text] [Related]
6. Studying the biological feasibility of [⁹⁹mTc(CO)₃]-dextran-cysteine-cysteine-mannose as a potential molecular radiopharmaceutical for sentinel node detection. Khan IU; Shahid A; Ahmad F; Dar UK; Ahmad M; Javed M Ann Nucl Med; 2014 Apr; 28(3):248-56. PubMed ID: 24390658 [TBL] [Abstract][Full Text] [Related]
7. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. Vera DR; Wallace AM; Hoh CK; Mattrey RF J Nucl Med; 2001 Jun; 42(6):951-9. PubMed ID: 11390562 [TBL] [Abstract][Full Text] [Related]
8. Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping. Yamaguchi A; Hanaoka H; Pirmettis I; Uehara T; Tsushima Y; Papadopoulos M; Arano Y Mol Pharm; 2015 Feb; 12(2):514-9. PubMed ID: 25423619 [TBL] [Abstract][Full Text] [Related]
9. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs. Méndez J; Wallace AM; Hoh CK; Vera DR J Nucl Med; 2003 Oct; 44(10):1677-81. PubMed ID: 14530486 [TBL] [Abstract][Full Text] [Related]
10. Size and specificity of radiopharmaceuticals for sentinel lymph node detection. Núñez EG; Teodoro R; Wiecek DP; da Silva NG; Martinelli JR; de Oliveira Filho RS Acta Radiol; 2011 Sep; 52(7):774-8. PubMed ID: 21558148 [TBL] [Abstract][Full Text] [Related]
11. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. Ellner SJ; Hoh CK; Vera DR; Darrah DD; Schulteis G; Wallace AM Nucl Med Biol; 2003 Nov; 30(8):805-10. PubMed ID: 14698783 [TBL] [Abstract][Full Text] [Related]
12. Comparative biological evaluation of two [99mTc(CO)3]-dextran pyrazolyl mannose conjugates developed for use in sentinel lymph node detection. Subramanian S; Pandey U; Morais M; Correia JD; Santos I; Samuel G Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):216-23. PubMed ID: 24172653 [TBL] [Abstract][Full Text] [Related]
13. Combining dose and injection volume for good performance of a specific radiopharmaceutical for sentinel node detection. Núñez EG; de Oliveira EA; da Silva NG; Filho RS Nucl Med Biol; 2012 Jan; 39(1):145-53. PubMed ID: 22079036 [TBL] [Abstract][Full Text] [Related]
14. [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection. Vera DR; Wallace AM; Hoh CK Nucl Med Biol; 2001 Jul; 28(5):493-8. PubMed ID: 11516693 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of receptor-based tumor imaging agent: (99m)Tc-folate-glucaric acid. Onursal M; Lambrecht FY; Ozgur A Int J Pharm; 2011 Sep; 416(1):288-92. PubMed ID: 21782912 [TBL] [Abstract][Full Text] [Related]
16. Modification of PLGA nanoparticles for improved properties as a 99mTc-labeled agent in sentinel lymph node detection. Subramanian S; Pandey U; Gugulothu D; Patravale V; Samuel G Cancer Biother Radiopharm; 2013 Oct; 28(8):598-606. PubMed ID: 23705864 [TBL] [Abstract][Full Text] [Related]
17. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model. Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595 [TBL] [Abstract][Full Text] [Related]
18. Kit for preparation of multimeric receptor-specific ⁹⁹mTc-radiopharmaceuticals based on gold nanoparticles. Ocampo-García B; Ferro-Flores G; Morales-Avila E; Ramírez Fde M Nucl Med Commun; 2011 Nov; 32(11):1095-104. PubMed ID: 21860334 [TBL] [Abstract][Full Text] [Related]
19. Novel Yin G; Ruan Q; Jiang Y; Feng J; Han P; Wang Q; Li Z; Zhang J J Med Chem; 2024 Sep; 67(17):15796-15806. PubMed ID: 39058751 [No Abstract] [Full Text] [Related]
20. Preliminary evaluation of the potential of 99mTc carbonyl-DTPA-Rituximab as a tracer for sentinel lymph node detection. Kameswaran M; Subramanian S; Pandey U; Samuel G Appl Radiat Isot; 2016 Jan; 107():195-198. PubMed ID: 26524405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]